世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測

• 英文タイトル：Global Diabetic Macular Edema Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7092
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、糖尿病性黄斑浮腫の治療のグローバル市場について調査・分析したレポートで、種類別（レーザー光凝固療法、薬理学療法、ベバシズマブ、ラニビズマブ、トリアムシノロン）、用途別（病院、眼科診療所、研究機関、受託研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・糖尿病性黄斑浮腫の治療の世界市場規模
・主要企業別市場シェア
・糖尿病性黄斑浮腫の治療の世界市場規模：種類別（レーザー光凝固療法、薬理学療法、ベバシズマブ、ラニビズマブ、トリアムシノロン）
・糖尿病性黄斑浮腫の治療の世界市場規模：用途別（病院、眼科診療所、研究機関、受託研究機関）
・糖尿病性黄斑浮腫の治療のアメリカ市場規模（種類別、用途別）
・糖尿病性黄斑浮腫の治療のヨーロッパ市場規模（種類別、用途別）
・糖尿病性黄斑浮腫の治療の中国市場規模（種類別、用途別）
・糖尿病性黄斑浮腫の治療の日本市場規模（種類別、用途別）
・糖尿病性黄斑浮腫の治療の東南アジア市場規模（種類別、用途別）
・糖尿病性黄斑浮腫の治療のインド市場規模（種類別、用途別）
・糖尿病性黄斑浮腫の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・糖尿病性黄斑浮腫の治療の世界市場予測（2019年-2025年）
・糖尿病性黄斑浮腫の治療の地域別市場予測（2019年-2025年）
...

Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.Increasing prevalence of diabetes in the prime factor driving growth of global diabetic macular edema therapeutics market. The prevalence of diabetic macular edema is higher in type 2 diabetes patients than in type 1 diabetes patients. As per study conducted by University Hospital Sant Joan de Reus Spain, the incidence of diabetic macular edema is in the range of 0.9%-2.3%, annually, across the globe. Besides this, substantial R&D investment by pharmaceutical companies and advancement in ophthalmic surgrey techniques are some other factors fueling the growth of global diabetic macular edema treatment market.
In 2018, the global Diabetic Macular Edema Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Diabetic Macular Edema Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Macular Edema Treatment development in United States, Europe and China.

The key players covered in this study
Genentech
Novartis
GlaxoSmithKline
Eyetech Pharmaceuticals
Alimera Sciences
…

Market segment by Type, the product can be split into
Laser Photocoagulation Therapy
Pharmacological Therapy
Bevacizumab
Ranibizumab
Triamcinolone

Market segment by Application, split into
Hospitals
Ophthalmic Clinics
Research Institutes
Contract Research Organizations

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diabetic Macular Edema Treatment status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Macular Edema Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetic Macular Edema Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Laser Photocoagulation Therapy
1.4.3 Pharmacological Therapy
1.4.4 Bevacizumab
1.4.5 Ranibizumab
1.4.6 Triamcinolone
1.5 Market by Application
1.5.1 Global Diabetic Macular Edema Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ophthalmic Clinics
1.5.4 Research Institutes
1.5.5 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Diabetic Macular Edema Treatment Market Size
2.2 Diabetic Macular Edema Treatment Growth Trends by Regions
2.2.1 Diabetic Macular Edema Treatment Market Size by Regions (2014-2025)
2.2.2 Diabetic Macular Edema Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Diabetic Macular Edema Treatment Market Size by Manufacturers
3.1.1 Global Diabetic Macular Edema Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Diabetic Macular Edema Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diabetic Macular Edema Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Macular Edema Treatment Key Players Head office and Area Served
3.3 Key Players Diabetic Macular Edema Treatment Product/Solution/Service
3.4 Date of Enter into Diabetic Macular Edema Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Diabetic Macular Edema Treatment Market Size by Type (2014-2019)
4.2 Global Diabetic Macular Edema Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Diabetic Macular Edema Treatment Market Size (2014-2019)
5.2 Diabetic Macular Edema Treatment Key Players in United States
5.3 United States Diabetic Macular Edema Treatment Market Size by Type
5.4 United States Diabetic Macular Edema Treatment Market Size by Application

6 Europe
6.1 Europe Diabetic Macular Edema Treatment Market Size (2014-2019)
6.2 Diabetic Macular Edema Treatment Key Players in Europe
6.3 Europe Diabetic Macular Edema Treatment Market Size by Type
6.4 Europe Diabetic Macular Edema Treatment Market Size by Application

7 China
7.1 China Diabetic Macular Edema Treatment Market Size (2014-2019)
7.2 Diabetic Macular Edema Treatment Key Players in China
7.3 China Diabetic Macular Edema Treatment Market Size by Type
7.4 China Diabetic Macular Edema Treatment Market Size by Application

8 Japan
8.1 Japan Diabetic Macular Edema Treatment Market Size (2014-2019)
8.2 Diabetic Macular Edema Treatment Key Players in Japan
8.3 Japan Diabetic Macular Edema Treatment Market Size by Type
8.4 Japan Diabetic Macular Edema Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Diabetic Macular Edema Treatment Market Size (2014-2019)
9.2 Diabetic Macular Edema Treatment Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Macular Edema Treatment Market Size by Type
9.4 Southeast Asia Diabetic Macular Edema Treatment Market Size by Application

10 India
10.1 India Diabetic Macular Edema Treatment Market Size (2014-2019)
10.2 Diabetic Macular Edema Treatment Key Players in India
10.3 India Diabetic Macular Edema Treatment Market Size by Type
10.4 India Diabetic Macular Edema Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Diabetic Macular Edema Treatment Market Size (2014-2019)
11.2 Diabetic Macular Edema Treatment Key Players in Central & South America
11.3 Central & South America Diabetic Macular Edema Treatment Market Size by Type
11.4 Central & South America Diabetic Macular Edema Treatment Market Size by Application

12 International Players Profiles
12.1 Genentech
12.1.1 Genentech Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Macular Edema Treatment Introduction
12.1.4 Genentech Revenue in Diabetic Macular Edema Treatment Business (2014-2019)
12.1.5 Genentech Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Macular Edema Treatment Introduction
12.2.4 Novartis Revenue in Diabetic Macular Edema Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Macular Edema Treatment Introduction
12.3.4 GlaxoSmithKline Revenue in Diabetic Macular Edema Treatment Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Eyetech Pharmaceuticals
12.4.1 Eyetech Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Macular Edema Treatment Introduction
12.4.4 Eyetech Pharmaceuticals Revenue in Diabetic Macular Edema Treatment Business (2014-2019)
12.4.5 Eyetech Pharmaceuticals Recent Development
12.5 Alimera Sciences
12.5.1 Alimera Sciences Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Macular Edema Treatment Introduction
12.5.4 Alimera Sciences Revenue in Diabetic Macular Edema Treatment Business (2014-2019)
12.5.5 Alimera Sciences Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Diabetic Macular Edema Treatment Key Market Segments
Table Key Players Diabetic Macular Edema Treatment Covered
Table Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Diabetic Macular Edema Treatment Market Size Market Share by Type 2014-2025
Figure Laser Photocoagulation Therapy Figures
Table Key Players of Laser Photocoagulation Therapy
Figure Pharmacological Therapy Figures
Table Key Players of Pharmacological Therapy
Figure Bevacizumab Figures
Table Key Players of Bevacizumab
Figure Ranibizumab Figures
Table Key Players of Ranibizumab
Figure Triamcinolone Figures
Table Key Players of Triamcinolone
Table Global Diabetic Macular Edema Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ophthalmic Clinics Case Studies
Figure Research Institutes Case Studies
Figure Contract Research Organizations Case Studies
Figure Diabetic Macular Edema Treatment Report Years Considered
Table Global Diabetic Macular Edema Treatment Market Size 2014-2025 (Million US$)
Figure Global Diabetic Macular Edema Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Diabetic Macular Edema Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Diabetic Macular Edema Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Diabetic Macular Edema Treatment Market Share by Regions 2014-2019
Figure Global Diabetic Macular Edema Treatment Market Share by Regions 2014-2019
Figure Global Diabetic Macular Edema Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Diabetic Macular Edema Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Diabetic Macular Edema Treatment Market Share by Manufacturers (2014-2019)
Figure Global Diabetic Macular Edema Treatment Market Share by Manufacturers in 2018
Table Global Diabetic Macular Edema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Diabetic Macular Edema Treatment Product/Solution/Service
Table Date of Enter into Diabetic Macular Edema Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Diabetic Macular Edema Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Diabetic Macular Edema Treatment Market Size Share by Type (2014-2019)
Figure Global Diabetic Macular Edema Treatment Market Size Market Share by Type (2014-2019)
Table Global Diabetic Macular Edema Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Diabetic Macular Edema Treatment Market Size Share by Application (2014-2019)
Figure Global Diabetic Macular Edema Treatment Market Size Market Share by Application (2014-2019)
Figure Global Diabetic Macular Edema Treatment Revenue Market Share by Application in 2018
Figure United States Diabetic Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Diabetic Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Diabetic Macular Edema Treatment Market Share (2018-2019)
Table United States Diabetic Macular Edema Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Diabetic Macular Edema Treatment Market Share by Type (2014-2019)
Table United States Diabetic Macular Edema Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Diabetic Macular Edema Treatment Market Share by Application (2014-2019)
Figure Europe Diabetic Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Diabetic Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Diabetic Macular Edema Treatment Market Share (2018-2019)
Table Europe Diabetic Macular Edema Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Diabetic Macular Edema Treatment Market Share by Type (2014-2019)
Table Europe Diabetic Macular Edema Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Diabetic Macular Edema Treatment Market Share by Application (2014-2019)
Figure China Diabetic Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Diabetic Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Diabetic Macular Edema Treatment Market Share (2018-2019)
Table China Diabetic Macular Edema Treatment Market Size by Type (2014-20189) (Million US$)
Table China Diabetic Macular Edema Treatment Market Share by Type (2014-2019)
Table China Diabetic Macular Edema Treatment Market Size by Application (2014-2019) (Million US$)
Table China Diabetic Macular Edema Treatment Market Share by Application (2014-2019)
Figure Japan Diabetic Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Diabetic Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Diabetic Macular Edema Treatment Market Share (2018-2019)
Table Japan Diabetic Macular Edema Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Diabetic Macular Edema Treatment Market Share by Type (2014-2019)
Table Japan Diabetic Macular Edema Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Diabetic Macular Edema Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Diabetic Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Diabetic Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Diabetic Macular Edema Treatment Market Share (2018-2019)
Table Southeast Asia Diabetic Macular Edema Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Diabetic Macular Edema Treatment Market Share by Type (2014-2019)
Table Southeast Asia Diabetic Macular Edema Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Diabetic Macular Edema Treatment Market Share by Application (2014-2019)
Figure India Diabetic Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Diabetic Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Diabetic Macular Edema Treatment Market Share (2018-2019)
Table India Diabetic Macular Edema Treatment Market Size by Type (2014-2019) (Million US$)
Table India Diabetic Macular Edema Treatment Market Share by Type (2014-2019)
Table India Diabetic Macular Edema Treatment Market Size by Application (2014-2019) (Million US$)
Table India Diabetic Macular Edema Treatment Market Share by Application (2014-2019)
Figure Central & South America Diabetic Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Diabetic Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Diabetic Macular Edema Treatment Market Share (2018-2019)
Table Central & South America Diabetic Macular Edema Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Diabetic Macular Edema Treatment Market Share by Type (2014-2019)
Table Central & South America Diabetic Macular Edema Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Diabetic Macular Edema Treatment Market Share by Application (2014-2019)
Table Genentech Company Details
Table Genentech Revenue in Diabetic Macular Edema Treatment Business (2014-2019) (Million US$)
Figure Genentech Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2014-2019)
Table Genentech Recent Development
Table Novartis Company Details
Table Novartis Revenue in Diabetic Macular Edema Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Diabetic Macular Edema Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Eyetech Pharmaceuticals Company Details
Table Eyetech Pharmaceuticals Revenue in Diabetic Macular Edema Treatment Business (2014-2019)(Million US$)
Figure Eyetech Pharmaceuticals Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2014-2019)
Table Eyetech Pharmaceuticals Recent Development
Table Alimera Sciences Company Details
Table Alimera Sciences Revenue in Diabetic Macular Edema Treatment Business (2014-2019)(Million US$)
Figure Alimera Sciences Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2014-2019)
Table Alimera Sciences Recent Development
Table Global Diabetic Macular Edema Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Diabetic Macular Edema Treatment Market Size Share by Regions (2019-2025)
Figure Global Diabetic Macular Edema Treatment Market Size Share by Regions in 2025
Figure United States Diabetic Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Diabetic Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Diabetic Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Diabetic Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Diabetic Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Diabetic Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Diabetic Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Diabetic Macular Edema Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Diabetic Macular Edema Treatment Market Size by Product (2019-2025)
Figure Global Diabetic Macular Edema Treatment Market Size by Product in 2025
Table Global Diabetic Macular Edema Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Diabetic Macular Edema Treatment Market Size by Application (2019-2025)
Figure Global Diabetic Macular Edema Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の黄斑浮腫治療薬市場：市場規模・現状・予測

Global Macular Edema Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7495 2019年6月14日 109Pages
当資料は、黄斑浮腫治療薬のグローバル市場について調査・分析したレポートで、種類別（レーザー治療、抗VEGF注射、抗炎症治療、硝子体手術）、用途別（嚢胞状黄斑浮腫（CME）、糖尿病性黄斑浮腫（DME））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関...

世界の嚢胞状黄斑浮腫市場：市場規模・現状・予測

Global Cystoid Macular Edema Market Size, Status and Forecast 2019-2025
QYR9N7056 2019年6月14日 95Pages
当資料は、嚢胞状黄斑浮腫のグローバル市場について調査・分析したレポートで、種類別（非ステロイド性抗炎症薬、抗血管内皮細胞増殖因子（VEGF）剤、炭酸アンヒドラーゼ阻害剤、ステロイド）、用途別（病院、外来手術センター、その他、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米...

世界の黄斑変性症の治療市場：市場規模・現状・予測

Global Macular Degeneration Treatment Market Size, Status and Forecast 2019-2025
QYR9N7494 2019年6月14日 99Pages
当資料は、黄斑変性症の治療のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、その他）、用途別（病院、アイクリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...

世界の肺水腫の治療市場：市場規模・現状・予測

Global Pulmonary Edema Treatment Market Size, Status and Forecast 2019-2025
QYR9N7909 2019年6月14日 97Pages
当資料は、肺水腫の治療のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院と診療所、学術機関、小売薬局、家庭、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の肺水腫市場：市場規模・現状・予測

Global Pulmonary Edema Market Size, Status and Forecast 2019-2025
QYR9N7908 2019年6月14日 97Pages
当資料は、肺水腫のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院と診療所、学術機関、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・肺水腫の...

世界の黄斑変性症の薬市場：市場規模・現状・予測

Global Macular Degeneration Drugs Market Size, Status and Forecast 2019-2025
QYR9N7493 2019年6月14日 97Pages
当資料は、黄斑変性症の薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、スクアラミン、Concecept、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...

世界の糖尿病性網膜症治療薬市場：市場規模・現状・予測

Global Diabetic Retinopathy Drugs Market Size, Status and Forecast 2019-2025
QYR9N7094 2019年6月14日 93Pages
当資料は、糖尿病性網膜症治療薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、オプティナ、イルヴィアン、ベタメタゾン、オズルデックス、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、...

世界の糖尿病性ケトアシドーシス治療市場：市場規模・現状・予測

Global Diabetic Ketoacidosis Treatments Market Size, Status and Forecast 2019-2025
QYR9N7091 2019年6月14日 96Pages
当資料は、糖尿病性ケトアシドーシス治療のグローバル市場について調査・分析したレポートで、種類別（補液、電解液の交換、インスリン療法）、用途別（病院、外来治療センター、専門クリニック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界の糖尿病性神経障害薬市場：市場規模・現状・予測

Global Diabetic Neuropathy Drugs Market Size, Status and Forecast 2019-2025
QYR9N7093 2019年6月14日 93Pages
当資料は、糖尿病性神経障害薬のグローバル市場について調査・分析したレポートで、種類別（カルシウムチャンネルアルファ-2デルタリガンド、SNRIとTCA、その他）、用途別（病院、ドラッグストア、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関...

世界の糖尿病性足部潰瘍治療薬市場：市場規模・現状・予測

Global Diabetic Foot Ulcer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7090 2019年6月14日 94Pages
当資料は、糖尿病性足部潰瘍治療薬のグローバル市場について調査・分析したレポートで、種類別（事前創傷包帯、代用皮膚、陰圧創傷治療装置、成長因子）、用途別（病院、専門クリニック、介護センター、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...

世界の黄斑浮腫治療薬市場：市場規模・現状・予測 Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cys…
世界の嚢胞状黄斑浮腫市場：市場規模・現状・予測 Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disrupti…
世界のラニビズマブ市場：市場規模・現状・予測 Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-relate…
世界の黄斑変性症の治療市場：市場規模・現状・予測 Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that m…
世界の肺水腫の治療市場：市場規模・現状・予測 Pulmonary edema refers to the generation and reflux imbalance of tissue fluid in the lung caused by some reasons, so that a large number of tissue fluid in a very short period of time can not be absorbed by the pulmonary lymphatic and pulmonary vein system, from the pulmonary capillary osmosis, accu…